Shotgun‐proteomics‐based clinical testing for diagnosis and classification of amyloidosis
- 3 October 2013
- journal article
- research article
- Published by Wiley in Journal of Mass Spectrometry
- Vol. 48 (10), 1067-1077
- https://doi.org/10.1002/jms.3264
Abstract
Shotgun proteomics technology has matured in the research laboratories and is poised to enter clinical laboratories. However, the road to this transition is sprinkled with major technical unknowns such as long‐term stability of the platform, reproducibility of the technology and clinical utility over traditional antibody‐based platforms. Further, regulatory bodies that oversee the clinical laboratory operations are unfamiliar with this new technology. As a result, diagnostic laboratories have avoided using shotgun proteomics for routine diagnostics. In this perspectives article, we describe the clinical implementation of a shotgun proteomics assay for amyloid subtyping, with a special emphasis on standardizing the platform for better quality control and earning clinical acceptance. This assay is the first shotgun proteomics assay to receive regulatory approval for patient diagnosis. The blueprint of this assay can be utilized to develop novel proteomics assays for detecting numerous other disease pathologies. Copyright © 2013 John Wiley & Sons, Ltd.Keywords
This publication has 59 references indexed in Scilit:
- Quality assessment for clinical proteomicsClinical Biochemistry, 2012
- Proteomic workflow for analysis of archival formalin‐fixed and paraffin‐embedded clinical samples to a depth of 10 000 proteinsProteomics – Clinical Applications, 2012
- Mass spectrometric immunoassay for quantitative determination of transthyretin and its variantsProteomics, 2011
- A novel approach for the purification and proteomic analysis of pathogenic immunoglobulin free light chains from serumBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2011
- Classification of amyloidosis by laser microdissection and mass spectrometry–based proteomic analysis in clinical biopsy specimensBlood, 2009
- Identification of Transthyretin Variants by Sequential Proteomic and Genomic AnalysisClinical Chemistry, 2004
- Proteomic Characterization of Postmortem Amyloid Plaques Isolated by Laser Capture MicrodissectionPublished by Elsevier BV ,2004
- Variant transthyretin (TTR) amyloidosis in Argentina. Detection of the trait by electrospray ionization mass spectrometry of lyophilized TTR immunoprecipitateScandinavian Journal of Clinical and Laboratory Investigation, 1999
- Characterization of Transthyretin Mutants from Serum Using Immunoprecipitation, HPLC/Electrospray Ionization and Matrix-Assisted Laser Desorption/Ionization Mass SpectrometryAnalytical Chemistry, 1998
- Simple detection of abnormal serum transthyretin from patients with familial amyloidotic polyneuropathy by high-performance liquid chromatography/electrospray ionization mass spectrometry using material precipitated with specific antiserumJournal of Mass Spectrometry, 1996